ZGEN: They are not going to comment definitively on this sort of strategy question because there's no advantage to them in doing so for now.
You just answered your previous question regarding sales forecasts for RECOTHROM. They could do it, but there is no advantage to doing so. Essentially, imo, it would be a no-win situation. However, I'd certainly expect some modicum of an outlook for 2008 sales at the 1st Q CC.
Market Data 
Markets 
AI
